FDA Staff Recommends Limited Use of Edoxaban Blood Thinner

Share this content:
FDA staff recommends limited use of Daiichi's blood thinner
FDA staff recommends limited use of Daiichi's blood thinner
Credit: Reuters/Stringer A man walks past the head office of Japanese pharmaceutical company Daiichi Sankyo Co., Ltd. in Tokyo July 17, 2009. The drug, edoxaban, is a once-daily anticoagulant that inhibits Factor Xa, a protein that plays a central role in blood-clotting.
READ FULL ARTICLE From Reuters
Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

is free, fast, and customized just for you!




Already a member?

Sign In Now »